The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

(2010) T. V. Halbsguth et al.   BLOOD

Hodgkin's disease and age*

(2010) Lena Specht et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control

(2009) S. J. Proctor et al.   ANNALS OF ONCOLOGY

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

(2009) E. Brusamolino et al.   HAEMATOLOGICA

Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients

(2009) Arjan Diepstra et al.   JOURNAL OF CLINICAL ONCOLOGY

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

(2008) C. Kobe et al.   BLOOD